吃瓜不打烊

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Healthcare Helpline
    • 吃瓜不打烊 Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • Common Ground
    • Diagnosis: Debt
    • The Body Shops
    • Priced Out
    • Guns, Race, and Profit
    • Broken Rehab
    • Dead Zone
    • Denied
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Healthcare Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health
    All Topics

  • Medicare Advantage Billing Probe
  • School Vaccine Mandates
  • Weight Loss Drugs Coverage
  • Opioid Settlement Money
  • Abortion Pill Access

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Thursday, Jun 14 2018

Full Issue

This Scientist's 'Reason To Live'? Helping Others Fight The Disease That Has Ravaged His Body

Rahul Desikan had just begun the biggest study ever of the genetics of ALS when he himself was diagnosed with the disease. Now he's continuing his research even as the condition takes its toll on his health. In other public health news: cellular recycling, JUUL, fertility treatments, IBM's Watson, gang violence, and living wills.

Rahul Desikan sits at his dining room table, a large computer screen before him, and works on his latest scientific paper. He types a single letter, then another, then another. For a man in a hurry, desperately trying to rid the world of terrible diseases, it鈥檚 an excruciatingly slow process. Using a special mouse strapped to his forehead that detects his smallest movement, Desikan moves a cursor around an on-screen keyboard. When he finds the letter he wants, he clicks a button with his right thumb, and it appears in a white space to the side. Repeating the process over and over, he debates research ideas with colleagues, analyzes reams of data and competes for grants. He types so much that he occasionally wears out the clicker. (McGinley, 6/13)

Agrowing number of small companies and a few large drug makers are taking a serious look at co-opting cellular recycling, or autophagy, as a way to treat disease. Cells use this process, whose Greek roots mean 鈥渟elf-eating,鈥 to clear damaged proteins, adapt to starvation, or fight infection, all by digesting their own contents. When autophagy鈥檚 essential genes are mutated and the process goes wrong, diseases from cancer to inflammatory bowel disease to Parkinson鈥檚 can result. (Cooney, 6/14)

Tevi Troy helped lead the nation's health department under President George W. Bush. Now he's helping steer JUUL 鈥斅爐he nation's most popular e-cigarette company 鈥斅爐hrough the Washington policymaking process and public health scrutiny. "Using a JUUL is worse than doing nothing," Troy acknowledged on the podcast. But"if we can get people to switch away from [traditional] cigarettes鈥 there's a potentially huge public health benefit." (Diamond, 6/13)

It used to be that cancer patients gave up on having children of their own, but with technological advances in reproductive medicine, there are options now. Many younger patients go through treatments to preserve their fertility; they extract eggs, bank sperm and freeze embryos. But when cancer patients want a chance at parenthood, who pays for the expensive treatments? (Dillon, 6/13)

When IBM launched its Watson Health division three years ago, promising to revolutionize medicine, not everyone in the sprawling technology company was on board. An existing group of employees was already working with health care clients and had its own secure cloud to store data, according to two former employees. But the new Watson Health team, with headquarters in Cambridge, Mass., started promoting another cloud, creating what seemed to be duplication 鈥 even competition 鈥 between old and new guards. (Ross and Swetlitz, 6/14)

Instead of tagging graffiti, some rival gang members now upload video of themselves chanting slurs in enemy territory. Taunts and fights that once played out over time on the street are these days hurled instantaneously on Twitter and Instagram. The online aggression can quickly translate into outbreaks of real violence 鈥 teens killing each other over emoji and virtually relayed gang signs. Social media have profoundly changed gang activity in the United States, according to a new report by a Chicago nonprofit. Of particular concern, researchers say, is how social media often appear to amplify and speed up the cycle of aggression and violence. (Wan, 6/13)

Kaiser Health News: That 鈥楲iving Will鈥 You Signed? At The ER, It Could Be Open To Interpretation.

鈥淒on鈥檛 resuscitate this patient; he has a living will,鈥 the nurse told Dr. Monica Williams-Murphy, handing her a document. Williams-Murphy looked at the sheet bearing the signature of the unconscious 78-year-old man, who鈥檇 been rushed from a nursing home to the emergency room. 鈥淒o everything possible,鈥 it read, with a check approving cardiopulmonary resuscitation. (Graham, 6/14)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, August 7
  • Thursday, August 6
  • Wednesday, August 5
  • Tuesday, August 4
  • Monday, August 3
  • Friday, July 31
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • 吃瓜不打烊
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

漏 2026 KFF